STAT

You’ve swum with one, stepped on one, maybe swallowed one. This unsung invertebrate could teach us about aging

Behold the rotifer, an unsung invertebrate that could help untangle the biology of aging.

WOODS HOLE, Mass. — In case you were wondering, Kristin Gribble is not a basher of fruit flies or roundworms. She wants to be clear: She bears no ill will toward those invertebrates so often studied that they’ve become scientific celebrities, recognizable by their truncated Latin names. She knows that Drosophila and C. elegans are powerful tools. She understands the allure of experimenting on creatures we know better than we know ourselves.

As an ecologist, she also thinks we might come to know ourselves a little better — and perhaps, stave off certain indignities of old age — by scrutinizing less famous spineless creatures in the lab. She’s staked her career on a particularly obscure one, and hopes others might do the same. Three to five times a year, she makes a point of mingling with the telomere-researchers and cell-rejuvenators and longevity-hounds who populate scientific conferences on aging. Like everyone else, she’s there to give papers and exchange ideas. But she’s also on a mission: to preach the gospel of rotifers.

“I feel like a

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks